Medications

Merck sues to challenge new US drug price program

Merck filed a lawsuit Tuesday challenging a new White House-backed program to limit drug prices, calling the initiative an unconstitutional "extortion" that will harm pharmaceutical innovation.

Medications

FDA approves Xacduro for difficult-to-treat bacterial pneumonia

The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused ...

Psychology & Psychiatry

Has there finally been progress in treating schizophrenia?

For decades there has been almost no improvement in the medical treatment of schizophrenia, one of the most serious and devastating of all mental illnesses, but recent advances have raised hopes of progress.

Addiction

California's fentanyl problem is getting worse

California has allocated more than $1 billion in recent years to combat its opioid crisis. Much of the money has been used to distribute fentanyl test strips and the overdose reversal drug naloxone, as well as deliver medical ...

page 25 from 40